Investigating the Impact of Co-processed Excipients on the Formulation of Bromhexine Hydrochloride Orally Disintegrating Tablets (ODTs)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Investigating the Impact of Co-processed Excipients on the Formulation of Bromhexine Hydrochloride Orally Disintegrating Tablets (ODTs) ; day:19 ; month:9 ; year:2023 ; pages:1-16
Pharmaceutical research ; (19.9.2023), 1-16
- Urheber
-
Woyna-Orlewicz, Krzysztof
Brniak, Witold
Tatara, Wiktor
Strzebońska, Magdalena
Haznar-Garbacz, Dorota
Szafraniec-Szczęsny, Joanna
Antosik-Rogóż, Agata
Wojteczko, Kamil
Strózik, Mirosław
Kurek, Mateusz
Jachowicz, Renata
Mendyk, Aleksander
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11095-023-03605-x
- URN
-
urn:nbn:de:101:1-2023120809023305801092
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Woyna-Orlewicz, Krzysztof
- Brniak, Witold
- Tatara, Wiktor
- Strzebońska, Magdalena
- Haznar-Garbacz, Dorota
- Szafraniec-Szczęsny, Joanna
- Antosik-Rogóż, Agata
- Wojteczko, Kamil
- Strózik, Mirosław
- Kurek, Mateusz
- Jachowicz, Renata
- Mendyk, Aleksander
- SpringerLink (Online service)
Ähnliche Objekte (12)
Formulation study of duloxetine hydrochloride enteric-coated tablets
Investigation of formulation and process parameters for the development of orally disintegrating tablets (ODTs) for migraine therapy
DEVELOPMENT OF GASTRO RETENTIVE FLOATING MATRIX TABLETS OF DILTIAZEM HYDROCHLORIDE
Preparation of taste masked orally disintegrating tablets by compression of coated pellets
Development and in Vitro/In Vivo Evaluation of Itopride Hydrochloride Expanding Tablets
Spectrophotometric quantification of amitriptyline hydrochloride in pharmaceutical tablets: method development and validation
Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine
Mesalazine granule formulation improves clinical data in Crohn's disease compared with tablet formulation
Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride
Co-Processed Excipients for Dispersible Tablets—Part 2: Patient Acceptability
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
Fabrication of Orally Fast-Disintegrating Wafer Tablets Containing Cannabis Extract Using Freeze-Drying Method
Formulation study of duloxetine hydrochloride enteric-coated tablets
Investigation of formulation and process parameters for the development of orally disintegrating tablets (ODTs) for migraine therapy
DEVELOPMENT OF GASTRO RETENTIVE FLOATING MATRIX TABLETS OF DILTIAZEM HYDROCHLORIDE
Preparation of taste masked orally disintegrating tablets by compression of coated pellets
Development and in Vitro/In Vivo Evaluation of Itopride Hydrochloride Expanding Tablets
Spectrophotometric quantification of amitriptyline hydrochloride in pharmaceutical tablets: method development and validation
Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine
Mesalazine granule formulation improves clinical data in Crohn's disease compared with tablet formulation
Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride
Co-Processed Excipients for Dispersible Tablets—Part 2: Patient Acceptability
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
Fabrication of Orally Fast-Disintegrating Wafer Tablets Containing Cannabis Extract Using Freeze-Drying Method
Formulation study of duloxetine hydrochloride enteric-coated tablets
Investigation of formulation and process parameters for the development of orally disintegrating tablets (ODTs) for migraine therapy
DEVELOPMENT OF GASTRO RETENTIVE FLOATING MATRIX TABLETS OF DILTIAZEM HYDROCHLORIDE
Preparation of taste masked orally disintegrating tablets by compression of coated pellets
Development and in Vitro/In Vivo Evaluation of Itopride Hydrochloride Expanding Tablets
Spectrophotometric quantification of amitriptyline hydrochloride in pharmaceutical tablets: method development and validation
Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine
Mesalazine granule formulation improves clinical data in Crohn's disease compared with tablet formulation
Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride
Co-Processed Excipients for Dispersible Tablets—Part 2: Patient Acceptability
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study